Array
(
[1600320981] => Array
(
[wordfence_batchReportBlockedAttempts] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1600321148] => Array
(
[wordfence_processAttackData] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1600321173] => Array
(
[wp_privacy_delete_old_export_files] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1600321681] => Array
(
[wpm_update_stats] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1600323885] => Array
(
[recovery_mode_clean_expired_keys] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1600324014] => Array
(
[wordfence_hourly_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1600326512] => Array
(
[ai1wm_storage_cleanup] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1600332571] => Array
(
[wp_scheduled_auto_draft_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1600337711] => Array
(
[delete_expired_transients] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1600337752] => Array
(
[wpseo-reindex-links] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1600338414] => Array
(
[wordfence_daily_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1600349526] => Array
(
[wp_update_themes] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_update_plugins] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1600350274] => Array
(
[wp_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1600350601] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[e8d760ad302ae8a03d9187eba4f9c463] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1600350601
)
)
)
)
[1600352953] => Array
(
[wp_version_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1600355873] => Array
(
[wp_session_garbage_collection] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1600358824] => Array
(
[akismet_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1600361811] => Array
(
[yoast_tracking] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1600609801] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[e021248f3c7fdf1e90f35aae4563002f] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1600609801
)
)
)
)
[1600696800] => Array
(
[wordfence_email_activity_report] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1600842290] => Array
(
[wp_site_health_scheduled_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => weekly
[args] => Array
(
)
[interval] => 604800
)
)
)
[1601157627] => Array
(
[publish_future_post] => Array
(
[aa3f9c41dd8e97586795881a0c603b8d] => Array
(
[schedule] =>
[args] => Array
(
[0] => 472787
)
)
)
)
)
Punto Farmacológico nº 117 del Consejo General de Colegios Oficiales de Farmacéuticos (CGCOF) sobre la esclerodermia. Esta corporación sanitaria de ámbito nacional llevó a cabo este documento con motivo de la celebración del Día Mundial de la mencionada enfermedad, que se conmemora cada 29 de junio.
Etiquetas: 117, 28 de junio de 2017, CGCOF, Consejo, Esclerodermia, Farmacológico, general, Madrid, Punto, Sanidad.
Etiquetas: 26 febrero 2008, 26/02/2008, Afecta a menos de 1 de cada 2.000 personas, Anemia de fanconi, Asistencia social, Asociaciones de Pacientes, Conocimiento médico, Déficit, Día Europeo de las Enfermedades Raras, Dolores crónicos, Enfermedad de pompe, Enfermedad de wilson, Enfermedades raras, Esclerodermia, Esclerosis Lateral Amiotrófica, EURORIS, Fármacos costosos, FEDER, Federación Española de Enfermedades Raras, Fibrosis quística, informe, Joubert, Leucodistrofia, Leucodistrofias, Madrid, Miopatía de duchenne, Nevus Gigante Congénito, Osteogénesis imperfecta, Paraparesia espástica familiar, Patologías mitocondriales, Rare Diseases Europe, salud, Sanidad, Síndrome de apert, Sindrome de tourette, Sistema Nacional de Salud, Situación de España con respecto a Europa, Situación socio-laboral, Vasculitis Sistémica, ¿Qué pasa en Europa?.
.gif)